DIANA GHELBER: Open Payments
NPI 1962720144 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 18 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $1,755 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $104 |
| Brainsway USA INC | 1 | $102 |
| Bausch Health US, LLC | 3 | $54 |
| ABBVIE INC. | 3 | $45 |
| Biogen, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: LYBALVI, CAPLYTA, Deep TMS System, VRAYLAR, WELLBUTRIN, ZURZUVAE, INGREZZA, APLENZIN.
Industry payments across TX — which companies pay providers there.
